Experimental group:DEB-TACE

4 trials

Sponsors

Shandong Institute of Cancer Prevention and Treatment, the First Affiliated Hospital,College of Medicine,Zhejiang University, Xi'an International Medical Center Hospital, Tianjin Third Central Hospital

Conditions

Hepatocellular CarcinomaHepatocellular carcinomaliver metastasis in coloretcal cancer

Phase 4

The correlation between subjective embolization endpoint and tumor response and a scoring model establishment for retreatment based on the subjective evaluation after DEB-TACE in patients with hepatocellular carcinoma

Active, not recruitingChiCTR2200065197

Tianjin Third Central HospitalHepatocellular carcinoma

Start: 2022-11-01Updated: 2023-05-15

Unknown Phase

Application and evaluation of drug-eluting beads in interventional therapy of liver metastasis in colorectal cancer

Active, not recruitingChiCTR1800017919

Shandong Institute of Cancer Prevention and Treatmentliver metastasis in coloretcal cancer

Start: 2018-09-03Updated: 2018-08-27

Clinical application research of drug-eluting beads transarterial chemoembolization with CalliSpheres beads for advanced hepatocellular carcinoma with portal vein tumor thrombus

Active, not recruitingChiCTR1800018035

the First Affiliated Hospital,College of Medicine,Zhejiang UniversityHepatocellular Carcinoma

Start: 2018-10-01Updated: 2018-09-03

Drug-releasing microsphere TACE (DEB-TACE) vs conventional lipiodol TACE (cTACE) in the treatment of unresectable liver cancer: a multicenter prospective study

RecruitingChiCTR2100050458

Xi'an International Medical Center HospitalHepatocellular Carcinoma

Start: 2021-09-15Updated: 2022-05-02

Related Papers

Comparison of drug-eluting bead with conventional transcatheter arterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a randomized clinical trial

International Journal of Surgery2024-05-229 citations